Arena Pharmaceuticals, Inc. files European marketing authorization application for lorcaserin for weight control (BioSpace, 2 March 2012)

06 Mar 2012


Arena Pharmaceuticals has applied to the European Medicines Agency for marketing authorisation for its new weight loss agent lorcaserin.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story